TruBridge (TBRG) AI Stock Analysis

• Market Cap: $357.11M
• Dividend Yield: N/A
• Average Volume (3M): 151.94K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.52
• Revenue Growth: 3.15%
• EPS Growth: 61.71%
• Country: US
• Employees: 3,200
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.36
• Shares Outstanding: 15,023,378
• 10 Day Avg. Volume: 131,466
• 30 Day Avg. Volume: 151,945
• PEG Ratio: -1.72
• Price to Book (P/B): 1.69
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 30.04
• Enterprise Value/Market Cap: 1.49
• Enterprise Value/Revenue: 0.39
• Enterprise Value/Gross Profit: 3.11
• Enterprise Value/Ebitda: 13.44
• 1Y Price Target: $29.00
• Price Target Upside: 25.70% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 64 Neutral
• Price Target: $25.00 ▲(8.37%Upside)

TruBridge is bolstered by strong financial stability and impressive earnings call results, particularly with improved EBITDA and cash flow. However, significant profitability challenges, as indicated by a negative P/E ratio and technical indicators showing a downward trend, limit the stock's current attractiveness. External uncertainties in healthcare funding and tariffs also pose potential risks.

TruBridge Business Overview & Revenue Model

Company Description

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.

How the Company Makes Money

TruBridge makes money through a diverse revenue model centered on providing essential services to healthcare organizations. Key revenue streams include subscription fees for its software solutions, service fees for revenue cycle management, and consulting fees for strategic advisory services. Additionally, TruBridge generates income from managed IT services, which help healthcare providers optimize their technology infrastructure. Significant partnerships with healthcare providers and technology partners enable TruBridge to expand its service offerings and maintain a steady flow of clients, contributing to its overall earnings.

TruBridge Financial Statement Overview

Summary

TruBridge exhibits strong revenue growth and a robust balance sheet with low leverage, indicating financial stability. However, persistent net losses highlight profitability challenges. Cash flow remains robust, supporting operational needs, but improving profitability is crucial for financial health.

Income Statement

TruBridge's TTM (Trailing-Twelve-Months) revenue shows modest growth, but net income remains negative, impacting net profit margins adversely. Gross profit margin is healthy at approximately 49.3%, indicating efficient cost management. However, negative net profit margins and fluctuating EBIT margins suggest challenges in profitability and operational efficiency.

Balance Sheet

The company's balance sheet reflects a strong equity position with an equity ratio of 43.3%. The debt-to-equity ratio is low at approximately 0.03, indicating low leverage and reduced financial risk. Despite this, a decline in total assets over time suggests potential concerns in asset management or reinvestment strategies.

Cash Flow

TruBridge's TTM (Trailing-Twelve-Months) operating cash flow is robust, leading to a favorable operating cash flow to net income ratio. Free cash flow has shown growth, but the free cash flow to net income ratio highlights issues due to negative net income figures. Overall, cash flow management appears strong despite profitability challenges.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
346.61M	342.65M	339.44M	326.65M	280.63M	264.49M
	Gross Profit
170.82M	174.12M	163.57M	160.11M	144.85M	136.25M
	EBIT
20.84M	6.63M	-42.60M	22.78M	24.71M	21.05M
	EBITDA
33.38M	34.94M	-15.39M	47.73M	43.11M	35.56M
	Net Income Common Stockholders
-17.25M	-20.44M	-45.79M	15.87M	18.43M	14.25M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
10.12M	12.32M	3.85M	6.95M	11.43M	12.67M
	Total Assets
388.84M	394.43M	434.42M	430.96M	383.35M	326.27M
	Total Debt
5.04M	174.81M	203.29M	147.24M	106.46M	83.43M
	Net Debt
-5.08M	162.49M	199.44M	140.29M	95.03M	70.76M
	Total Liabilities
220.33M	225.74M	247.80M	199.25M	160.78M	126.27M
	Stockholders Equity
168.51M	168.69M	186.62M	231.71M	222.57M	200.00M
Cash Flow		Free Cash Flow
25.49M	13.04M	-22.35M	13.01M	37.46M	42.48M
	Operating Cash Flow
39.93M	32.13M	1.06M	32.38M	47.74M	49.14M
	Investing Cash Flow
-14.51M	4.12M	-60.11M	-62.73M	-69.92M	-6.66M
	Financing Cash Flow
-19.41M	-27.74M	55.95M	25.88M	20.93M	-37.16M

TruBridge Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 23.07
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBRG, the sentiment is Negative. The current price of 23.07 is below the 20-day moving average (MA) of 24.05, below the 50-day MA of 24.72, and above the 200-day MA of 20.66, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 37.11 is Neutral, neither overbought nor oversold. The STOCH value of 30.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TBRG.

TruBridge Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VMD	75 Outperform	$267.97M	22.29	9.79%	―	19.97%	17.21%
CSTL	70 Outperform	$532.41M	30.59	-1.20%	―	38.43%	86.19%
TBRG	64 Neutral	$357.11M	―	-10.98%	―	3.15%	61.71%
TCMD	60 Neutral	$231.32M	14.86	8.12%	―	5.96%	-43.83%
DH	57 Neutral	$531.21M	―	-86.36%	―	-3.04%	-152.59%
Sector *	54 Neutral	$5.41B	3.27	-45.10%	3.29%	16.81%	0.02%
RNAC	47 Neutral	$265.77M	―	-938.38%	―	38.82%	-645.78%

TruBridge Corporate Events

TruBridge Announces Governance Changes at Annual Meeting

At the 2025 Annual Meeting held on May 8, 2025, TruBridge, Inc. announced significant corporate governance changes and approvals. The company’s stockholders approved the declassification of the Board of Directors, which will take effect starting with the 2026 Annual Meeting. Additionally, the Second Amended and Restated 2019 Incentive Plan was approved to increase the number of shares available for issuance. Other key decisions included the re-election of Class II directors, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent registered public accountants for 2025.